Medical device could diagnose respiratory infections with breath

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath.

Lower respiratory tract infections, such as bronchitis, pneumonia, and bronchiolitis, are currently diagnosed by culturing bacteria from respiratory specimens, but the procedure is invasive, laborious, and time intensive.

READ MORE: Respiratory tract microbiome influences the severity of bacterial pneumonia

READ MORE: Antibiotics aren’t effective for most lower tract respiratory infections

Molecular sequencing techniques cannot differentiate between clinical infection and mere colonization, in which bacteria are benignly present in the respiratory tract.

Human neutrophil elastase

Dapeng Chen and colleagues have designed a medical device that measures the protease activity of human neutrophil elastase in human breath with high sensitivity. The over-release of neutrophil proteases is an effect caused by lower respiratory tract infections.

The authors tested the system on clinical breath samples from intubated patients as well as a group of healthy volunteers. The platform measured elevated levels of human neutrophil elastase in patients diagnosed with confirmed lower respiratory tract infections.

According to the authors, the results suggest that developing a breath-based diagnostic tool for lower respiratory tract infections will be possible, which could be particularly useful in intubated patients within critical care settings.